Incidence and significance of incidental prostate carcinoma in transurethral resection (TUR-P) materials between 2014 and 2016 at our center. Like all organs, prostate has benign and malign diseases. Among benign diseases, benign prostatic hyperplasia (BPH) and among malignancies adenocarcinoma are the most common ones. One of the methods that is used to treat BPH is transurethral resection (TUR-P). In our study, we investigated incidental tumor rates observed in patients that have TUR-P due to BPH. We included 120 patients who underwent TUR-P and whose operation materials were examined in pathology department between 2014-2016 in our center. Benign diseases were noted in 117 (97.5%) of 120 patients, whereas malignant tumors were detected in 3 (2.5%) cases. In TUR-P operations performed to relieve symptoms in BPH, adenocarcinoma is reported in the literature at rates ranging from 4% to 15%. We suggest that patients with symptoms of prostatism should be carefully investigated, detailed histopathologic evaluation should be done in terms of incidental tumors and clinical pathology communication should be at maximum level.
Incidence and significance of incidental prostate carcinoma in
transurethral resection (TUR-P) materials between 2014 and 2016 at our center. Like
all organs, prostate has benign and malign diseases. Among benign diseases,
benign prostatic hyperplasia (BPH) and among malignancies adenocarcinoma are
the most common ones. One of the methods that is used to treat BPH is
transurethral resection (TUR-P). In our study, we investigated incidental tumor
rates observed in patients that have TUR-P due to BPH. We included 120 patients
who underwent TUR-P and whose operation materials were examined in pathology
department between 2014-2016 in our center. Benign diseases were noted in 117
(97.5%) of 120 patients, whereas malignant tumors were detected in 3 (2.5%)
cases. In TUR-P operations performed to relieve symptoms in BPH, adenocarcinoma
is reported in the literature at rates ranging from 4% to 15%. We suggest that patients
with symptoms of prostatism should be carefully investigated, detailed
histopathologic evaluation should be done in terms of incidental tumors and
clinical pathology communication should be at maximum level.
Primary Language | English |
---|---|
Subjects | Health Care Administration |
Journal Section | Articles |
Authors | |
Publication Date | April 21, 2018 |
Published in Issue | Year 2018 Volume: 13 Issue: 2 |